Home LiteratureArticle Details
PMID: 22696035 Published · ppublish English Journal Article Comment

Diabetic nephropathy in type 1 diabetes: has the outlook improved since the 1980s?

Diabetologia ·Vol. 55 ·No. 9 ·2012-09-00 ·Pages 2301-6

Marshall SM

Abstract

This edition of Then and Now discusses three papers published in Diabetologia in the 1980s relating to diabetic nephropathy. Two epidemiological papers by Andersen et al (1983; 25:496-501) and Borch-Johnsen et al (1985; 28:590-596) described in graphic detail the ravages of diabetic nephropathy in type 1 diabetes. After 40 years of diabetes, 41% of their cohort had developed persistent proteinuria. The median time from first appearance of proteinuria to death was 7-8 years, the majority dying of uraemia or cardiovascular disease. The third paper, by Mathiesen et al (1984; 26:406-410), identified individuals with microalbuminuria, a much earlier stage of diabetic nephropathy, and analysed the risk of progression to persistent proteinuria at various levels of urine albumin excretion. Since the description of microalbuminuria, clinicians have hoped that earlier identification of individuals at high risk of end-stage kidney disease, coupled with aggressive use of reno-protective therapies, would prevent, or at the very least significantly delay, the development of end-stage renal disease. Recent data suggest that the outlook has indeed improved since the 1980s, at least in some populations. However, we may be delaying rather than preventing the development of microalbuminuria, proteinuria and kidney failure. Whilst a delay of 10 or more years in the appearance of end-stage renal disease is very welcome, further work is needed to understand why rates of chronic kidney disease vary substantially between cohorts and to develop novel therapies.

MeSH Terms
Diabetes Mellitus, Type 1/complications,mortality,physiopathology Diabetic Nephropathies/diagnosis,epidemiology Female Humans Male Proteinuria/complications
Authors & Affiliations
1 authors, click to expand affiliations / ORCID
Marshall S M
Faculty of Clinical Medical Sciences, Institute of Cellular Medicine, Newcastle University, Floor 4, Leech Building, Framlington Place, Newcastle upon Tyne NE2 4HH, UK. sally.marshall@newcastle.ac.uk
References (33)
33 references, click to expand
  1. Cumulative risk, age at onset, and sex-specific differences for developing end-stage renal disease in young patients with type 1 diabetes: a nationwide population-based cohort study.
    Diabetes. 2010 Jul;59(7):1803-8 PMID: 20424230
  2. Declining incidence of severe retinopathy and persisting decrease of nephropathy in an unselected population of Type 1 diabetes-the Linköping Diabetes Complications Study.
    Diabetologia. 2004 Jul;47(7):1266-1272 PMID: 15235773
  3. Decreasing incidence of severe diabetic microangiopathy in type 1 diabetes.
    Diabetes Care. 2003 Apr;26(4):1258-64 PMID: 12663607
  4. Incipient nephropathy in type 1 (insulin-dependent) diabetes.
    Diabetologia. 1984 Jun;26(6):406-10 PMID: 6468791
  5. Long-term renal outcomes of patients with type 1 diabetes mellitus and microalbuminuria: an analysis of the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications cohort.
    Arch Intern Med. 2011 Mar 14;171(5):412-20 PMID: 21403038
  6. Microalbuminuria as a predictor of clinical nephropathy in insulin-dependent diabetes mellitus.
    Lancet. 1982 Jun 26;1(8287):1430-2 PMID: 6123720
  7. Sequence of progression of albuminuria and decreased GFR in persons with type 1 diabetes: a cohort study.
    Am J Kidney Dis. 2007 Nov;50(5):721-32 PMID: 17954285
  8. Clustering of risk factors in parents of patients with type 1 diabetes and nephropathy.
    Diabetes Care. 2007 May;30(5):1162-7 PMID: 17337502
  9. Diabetic nephropathy in Type 1 (insulin-dependent) diabetes: an epidemiological study.
    Diabetologia. 1983 Dec;25(6):496-501 PMID: 6363177
  10. Predicting diabetic nephropathy in insulin-dependent patients.
    N Engl J Med. 1984 Jul 12;311(2):89-93 PMID: 6738599
  11. URINARY ALBUMIN EXCRETION AND DIABETES MELLITUS.
    Lancet. 1964 Nov 28;2(7370):1155-6 PMID: 14213577
  12. Familial clustering of cardiovascular disease in patients with insulin-dependent diabetes and nephropathy.
    N Engl J Med. 1992 Mar 5;326(10):673-7 PMID: 1736105
  13. Remission of nephrotic-range albuminuria in type 1 diabetic patients.
    Diabetes Care. 2001 Nov;24(11):1972-7 PMID: 11679467
  14. Modern-day clinical course of type 1 diabetes mellitus after 30 years' duration: the diabetes control and complications trial/epidemiology of diabetes interventions and complications and Pittsburgh epidemiology of diabetes complications experience (1983-2005).
    Arch Intern Med. 2009 Jul 27;169(14):1307-16 PMID: 19636033
  15. Improved prognosis in type 1 diabetic patients with nephropathy: a prospective follow-up study.
    Kidney Int. 2005 Sep;68(3):1250-7 PMID: 16105058
  16. Towards understanding the inherited susceptibility for nephropathy in diabetes.
    Curr Opin Nephrol Hypertens. 2012 Mar;21(2):195-202 PMID: 22314557
  17. Risk for ESRD in type 1 diabetes remains high despite renoprotection.
    J Am Soc Nephrol. 2011 Mar;22(3):545-53 PMID: 21355053
  18. Renal replacement therapy for diabetic end-stage renal disease: data from 10 registries in Europe (1991-2000).
    Kidney Int. 2005 Apr;67(4):1489-99 PMID: 15780102
  19. Cohort study of predictive value of urinary albumin excretion for atherosclerotic vascular disease in patients with insulin dependent diabetes.
    BMJ. 1996 Apr 6;312(7035):871-4 PMID: 8611873
  20. Development and progression of renal insufficiency with and without albuminuria in adults with type 1 diabetes in the diabetes control and complications trial and the epidemiology of diabetes interventions and complications study.
    Diabetes Care. 2010 Jul;33(7):1536-43 PMID: 20413518
  21. Incidence of end-stage renal disease in patients with type 1 diabetes.
    JAMA. 2005 Oct 12;294(14):1782-7 PMID: 16219881
  22. The 30-year natural history of type 1 diabetes complications: the Pittsburgh Epidemiology of Diabetes Complications Study experience.
    Diabetes. 2006 May;55(5):1463-9 PMID: 16644706
  23. Nephropathy in type 1 diabetes: a manifestation of insulin resistance and multiple genetic susceptibilities? Further evidence from the Pittsburgh Epidemiology of Diabetes Complication Study.
    Kidney Int. 2002 Sep;62(3):963-70 PMID: 12164879
  24. AN IMMUNOASSAY METHOD FOR URINARY ALBUMIN AT LOW CONCENTRATIONS.
    Lancet. 1963 Nov 2;2(7314):913-4 PMID: 14052063
  25. The presence and severity of chronic kidney disease predicts all-cause mortality in type 1 diabetes.
    Diabetes. 2009 Jul;58(7):1651-8 PMID: 19401416
  26. Competing-risk analysis of ESRD and death among patients with type 1 diabetes and macroalbuminuria.
    J Am Soc Nephrol. 2011 Mar;22(3):537-44 PMID: 21335512
  27. The effect of proteinuria on relative mortality in type 1 (insulin-dependent) diabetes mellitus.
    Diabetologia. 1985 Aug;28(8):590-6 PMID: 4054448
  28. Regression of microalbuminuria in type 1 diabetes.
    N Engl J Med. 2003 Jun 5;348(23):2285-93 PMID: 12788992
  29. Predictors of mortality in insulin dependent diabetes: 10 year observational follow up study.
    BMJ. 1996 Sep 28;313(7060):779-84 PMID: 8842069
  30. Early detection of patients at risk of developing diabetic nephropathy. A longitudinal study of urinary albumin excretion.
    Acta Endocrinol (Copenh). 1982 Aug;100(4):550-5 PMID: 6812342
  31. Intensive diabetes therapy and glomerular filtration rate in type 1 diabetes.
    N Engl J Med. 2011 Dec 22;365(25):2366-76 PMID: 22077236
  32. Microalbuminuria and risk for cardiovascular disease: Analysis of potential mechanisms.
    J Am Soc Nephrol. 2006 Aug;17(8):2106-11 PMID: 16825333
  33. In the absence of renal disease, 20 year mortality risk in type 1 diabetes is comparable to that of the general population: a report from the Pittsburgh Epidemiology of Diabetes Complications Study.
    Diabetologia. 2010 Nov;53(11):2312-9 PMID: 20665208
Article Info
Journal
Diabetologia
Abbr.
Diabetologia
ISSN
1432-0428
Published
2012-09-00
Epub
2012-00-14
Pages
2301-6
Language
English
Region
Germany
NLM ID
0006777
Subset
IM
Corrections
CommentOn
CommentOn
CommentOn
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com